Oral fish oil positively influences nutritional ‐inflammatory risk in patients with haematological malignancies during chemotherapy with an impact on long‐term survival: a randomised clinical trial
ConclusionsThese findings indicate an improved nutritional‐inflammatory risk and potential effects on long‐term survival in patients with haematological malignancies supplemented with FO during the beginning of chemotherapy.
Source: Journal of Human Nutrition and Dietetics - Category: Nutrition Authors: T. R. Chagas, D. S. Borges, P. F. Oliveira, M. C. Mocellin, A. M. Barbosa, C. Q. Camargo, J. Â. G. Del Moral, A. Poli, P. C. Calder, E. B. S. M. Trindade, E. A. Nunes Tags: Research Paper Source Type: research
More News: Cancer & Oncology | Chemotherapy | Clinical Trials | Fish Oil | Leukemia | Lymphoma | Nutrition | Study